MANNKIND CORP Debt Instrument, Face Amount
MANNKIND CORP (MNKD) had Debt Instrument, Face Amount of $278.80 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2022-11-08
- 2022-09-30: Debt Instrument, Face Amount $278.80M.
- 2022-06-30: Debt Instrument, Face Amount $278.80M.
- 2022-03-31: Debt Instrument, Face Amount $288.40M.
- 2021-12-31: Debt Instrument, Face Amount $288.40M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2022-09-30 | $278.80M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $278.80M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $288.40M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $288.40M 10-K · filed 2022-02-24 |
| 2021-09-30 | $288.40M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $293.30M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $338.40M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $122.90M 10-K · filed 2021-02-25 |
| 2020-09-30 | $122.60M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $122.60M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $120.30M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $120.30M 10-K · filed 2020-02-25 |
| 2019-09-30 | $120.10M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $99.20M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $101.70M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $101.70M 10-K · filed 2019-02-26 |
| 2018-09-30 | $104.70M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $129.20M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $140.20M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $157.80M 10-K · filed 2018-02-27 |
| 2016-09-30 | $27.69M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $27.69M 10-Q/A · filed 2016-08-10 |
| 2015-12-31 | $27.69M 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |